Angiodynamic (ANGO) Stock Price
$9.11 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
6 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Angiodynamic, AI stock picks, stock alerts and much more.
ANGO AI Stock Analysis
AI stock analysis for ANGO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Angiodynamic (ANGO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Angiodynamic (ANGO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Angiodynamic (ANGO), currently trading at $9.11, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ANGO
-
AngioDynamics, Inc.
-
Symbol
ANGO
-
Market
NASDAQ
-
Industry
Medical - Instruments & Supplies
-
Market Cap
369.9M
Similar Stocks
 |
Dentsply XRAY |
$15.81 0.6% |
4 |
 |
Intuitive Surgical ISRG |
$536.5 0.3% |
6 |
 |
LeMaitre Vascular LMAT |
$80.26 1.5% |
7 |
 |
NovoCure NVCR |
$17.38 0.3% |
3 |
 |
ICU Medical ICUI |
$138.3 3.2% |
5 |
News
ANGO Alternative Data
Web Traffic
Angiodynamic receives an estimated 16549 monthly visitors to angiodynamics.com, which is up by 52.1% over the last month.
-
Web Traffic
16549
-
Change from Previous Month
52.1%
-
3 Month Change
24.2%
-
YoY Change
24.2%
Facebook Engagement
Angiodynamic has engaged 93 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
93
-
Daily Change
6.9%
-
1 Month Change
0%
-
3 Month Change
3000%
-
YoY Change
3000%
Youtube Subscribers
Angiodynamic has 1,750 subscribers on its main Youtube channel, up by 0.6% over the last month.
-
Youtube Subscribers
1750
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.7%
-
YoY Change
1.7%
LinkedIn Followers
28,447 are following Angiodynamic on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
28447
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
5.1%
Job Postings
Angiodynamic has an estimated 32 open job postings, which is down -22% over the last month.
-
Job Postings
32
-
Daily Change
3.2%
-
1 Month Change
22%
-
3 Month Change
88.2%
-
YoY Change
88.2%
LinkedIn Employees
According to LinkedIn, Angiodynamic has 943 employees, down by -1% over the last month.
-
LinkedIn Employees
943
-
Daily Change
0.2%
-
1 Month Change
1%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Reddit Mentions
Angiodynamic has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Angiodynamic has 1,528 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.
-
Twitter Followers
1528
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1.8%
-
YoY Change
1.8%
News Mentions
Angiodynamic was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Angiodynamic is 40 out of 100 (bearish).
-
Business Outlook
40
-
Change from Previous Month
7%
-
3 Month Change
0%
-
YoY Change
0%
ANGO Financials
ANGO Key Metrics
-
Total Revenue
$72M
-
Net Income
-$4.4M
-
Earnings per Share
-$0.11
-
Free cash flow
-$15M
-
EBITDA
-$329K
-
EBITDA Ratio
-0.00456919
-
Total Assets
$285.4M
ANGO 2-year Revenue & Income
ANGO 2-year Free Cash Flow
ANGO Technicals
ANGO SMA
ANGO RSI
FAQ
What's the current price of Angiodynamic (ANGO) Stock?
The price of an Angiodynamic (ANGO) share is $9.11.
What's the market cap of Angiodynamic?
The current market cap of Angiodynamic is 369.9M.
Should I buy or sell ANGO?
Angiodynamic shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Angiodynamic is better viewed as a hold or accumulate position while waiting for further developments.
Is Angiodynamic a good investment?
The current analysis of Angiodynamic's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Angiodynamic's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Angiodynamic (ANGO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Angiodynamic stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Angiodynamic (ANGO) that investors often compare it to?
Angiodynamic (ANGO) is often compared to similar stocks such as Dentsply, Intuitive Surgical, LeMaitre Vascular, NovoCure and ICU Medical.
What is the forecast for Angiodynamic's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Angiodynamic's stock price to be around $9.6 in 2026. Starting from the current price of $9.11, this represents a 5.4% change in price, indicating a bullish outlook for the stock.
How to buy Angiodynamic (ANGO) Stock?
Angiodynamic stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Angiodynamic shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.